Finance

Nasal spray maker secures $1.8 million in financing to promote product

Published in Respiratory Therapeutics Week, January 3rd, 2005

SinoFresh HealthCare, Inc. (SFSH), marketer of the over-the-counter nasal spray that kills bacteria and fungi, has secured financing in the amount of $1.8 million through the sale of senior secured 6% convertible debentures to current, private, and institutional investors.

The financing was arranged primarily to support the company's 2005 marketing and media plan.

The funds also will be used to pay off the company's current senior secured creditor and to meet costs of general business operations.

SinoFresh HealthCare, Inc. is a developer and marketer of therapies to treat inflammatory and infectious diseases of the upper...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week

Source: Respiratory Therapeutics Week (2005-01-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry